|Imaging and photodynamic therapy: mechanisms, monitoring and optimization|
JP Celli, BQ Spring, I Rizvi, CL Evans, KS Samkoe, S Verma, BW Pogue, ...
Chemical reviews 110 (5), 2795, 2010
|The molecular basis of vitamin D receptor and β-catenin crossregulation|
S Shah, MN Islam, S Dakshanamurthy, I Rizvi, M Rao, R Herrell, G Zinser, ...
Molecular cell 21 (6), 799-809, 2006
|A three‐dimensional in vitro ovarian cancer coculture model using a high‐throughput cell patterning platform|
F Xu, J Celli, I Rizvi, S Moon, T Hasan, U Demirci
Biotechnology journal 6 (2), 204-212, 2011
|Three-dimensional miniature endoscopy|
D Yelin, I Rizvi, WM White, JT Motz, T Hasan, BE Bouma, GJ Tearney
Nature 443 (7113), 765, 2006
|Targeted photodynamic therapy|
N Solban, I Rizvi, T Hasan
Lasers in surgery and medicine 38 (5), 522-531, 2006
|Pegylation of a chlorine6 polymer conjugate increases tumor targeting of photosensitizer|
MR Hamblin, JL Miller, I Rizvi, B Ortel, EV Maytin, T Hasan
Cancer research 61 (19), 7155-7162, 2001
|Synergism of Epidermal Growth Factor Receptor–Targeted Immunotherapy With Photodynamic Treatment of Ovarian Cancer In Vivo|
MG Del Carmen, I Rizvi, Y Chang, ACE Moor, E Oliva, M Sherwood, ...
Journal of the National Cancer Institute 97 (20), 1516-1524, 2005
|Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer|
I Rizvi, JP Celli, CL Evans, AO Abu-Yousif, A Muzikansky, BW Pogue, ...
Cancer research 70 (22), 9319-9328, 2010
|Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules|
I Rizvi, UA Gurkan, S Tasoglu, N Alagic, JP Celli, LB Mensah, Z Mai, ...
Proceedings of the National Academy of Sciences 110 (22), E1974-E1983, 2013
|The role of photodynamic therapy in overcoming cancer drug resistance|
BQ Spring, I Rizvi, N Xu, T Hasan
Photochemical & Photobiological Sciences 14 (8), 1476-1491, 2015
|An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models|
JP Celli, I Rizvi, AR Blanden, I Massodi, MD Glidden, BW Pogue, T Hasan
Scientific reports 4, 3751, 2014
|In vivo high-resolution fluorescence microendoscopy for ovarian cancer detection and treatment monitoring|
W Zhong, JP Celli, I Rizvi, Z Mai, BQ Spring, SH Yun, T Hasan
British journal of cancer 101 (12), 2015-2022, 2009
|Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1 A chlorine6 immunoconjugate|
M Del Governatore, MR Hamblin, CR Shea, I Rizvi, KG Molpus, ...
Cancer research 60 (15), 4200-4205, 2000
|A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer|
B Kosharskyy, N Solban, SK Chang, I Rizvi, Y Chang, T Hasan
Cancer research 66 (22), 10953-10958, 2006
|Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy|
MR Hamblin, JL Miller, I Rizvi, HG Loew, T Hasan
British journal of cancer 89 (5), 937, 2003
|Killing hypoxic cell populations in a 3D tumor model with EtNBS-PDT|
CL Evans, AO Abu-Yousif, YJ Park, OJ Klein, JP Celli, I Rizvi, X Zheng, ...
PLoS One 6 (8), e23434, 2011
|Ki-67 as a molecular target for therapy in an in vitro three-dimensional model for ovarian cancer|
R Rahmanzadeh, P Rai, JP Celli, I Rizvi, B Baron-Lühr, J Gerdes, ...
Cancer research 70 (22), 9234-9242, 2010
|In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment|
SK Chang, I Rizvi, N Solban, T Hasan
Clinical Cancer Research 14 (13), 4146-4153, 2008
|Biodistribution of charged 17.1 A photoimmunoconjugates in a murine model of hepatic metastasis of colorectal cancer|
MR Hamblin, M Del Governatore, I Rizvi, T Hasan
British journal of cancer 83 (11), 1544, 2000
|Quantitative imaging reveals heterogeneous growth dynamics and treatment-dependent residual tumor distributions in a three-dimensional ovarian cancer model|
JP Celli, I Rizvi, CL Evans, AO Abu-Yousif, T Hasan
Journal of biomedical optics 15 (5), 051603-051603-10, 2010